Abstract
AbstractThe acquisition of a metastatic phenotype is the critical event that determines patient survival from breast cancer. Several receptor tyrosine kinases have functions both in promoting and inhibiting metastasis in breast tumors. Although the insulin-like growth factor 1 receptor (IGF-1R) has been considered a target for inhibition in breast cancer, low levels of IGF-1R expression are associated with worse overall patient survival. To determine how reduced IGF-1R impacts tumor phenotype, we used weighted gene correlation network analysis (WGCNA) of METABRIC patient data and identified gene modules specific to cell cycle, adhesion, and immune cell signaling inversely correlated with IGF-1R expression in human breast cancers. Integration of human patient data with data from mouse tumors revealed similar pathways necessary for promoting metastasis in basal-like tumors with reduced signaling or expression of the IGF-1R. Functional analyses revealed the basis for the enhanced metastatic phenotype including alterations in E- and P-cadherins.
Publisher
Cold Spring Harbor Laboratory
Reference45 articles.
1. Diversity of insulin and IGF signaling in breast cancer: Implications for therapy
2. Ali R , Wendt MK . The paradoxical functions of EGFR during breast cancer progression. Signal Transduct Target Ther. 2017;2.
3. Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression
4. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas;Int J Clin Exp Pathol,2014
5. Targeting Insulin and Insulin-Like Growth Factor Signaling in Breast Cancer
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献